MYD88 L265P mutation in Waldenstrom macroglobulinemia

Distinctive Clinical and Histological Features of Waldenström's Macroglobulinemia and Splenic Marginal Zone Lymphoma

(2012) Luca Arcaini et al.   Clinical Lymphoma Myeloma & Leukemia

Molecular pathogenesis of Waldenstrom's macroglobulinemia

(2012) E. Braggio et al.   HAEMATOLOGICA

Chlamydia psittaci-negative ocular adnexal marginal zone B-cell lymphomas have biased V H 4-34 immunoglobulin gene expression and proliferate in a distinct inflammatory environment

(2012) F van Maldegem et al.   LEUKEMIA

IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas

(2012) N Gachard et al.   LEUKEMIA

MYD88 L265P Somatic Mutation in Waldenström's Macroglobulinemia

(2012) Steven P. Treon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Waldenström macroglobulinemia: 2011 update on diagnosis, risk stratification, and management

(2011) Morie A. Gertz   AMERICAN JOURNAL OF HEMATOLOGY

Establishment and characterization of a novel Waldenstrom macroglobulinemia cell line, MWCL-1

(2011) L. S. Hodge et al.   BLOOD

BCR and TLR signaling pathways are recurrently targeted by genetic changes in splenic marginal zone lymphomas

(2011) Q. Yan et al.   HAEMATOLOGICA

Oncogenic MYD88 mutation drives Toll pathway to lymphoma

(2011) Yogesh S Jeelall et al.   IMMUNOLOGY AND CELL BIOLOGY

Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia

(2011) Xose S. Puente et al.   NATURE

Selective inhibition of chymotrypsin-like activity of the immunoproteasome and constitutive proteasome in Waldenstrom macroglobulinemia

(2010) A. M. Roccaro et al.   BLOOD

Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome

(2010) A. Rinaldi et al.   BLOOD

SNP array analysis in hematologic malignancies: avoiding false discoveries

(2010) S. Heinrichs et al.   BLOOD

Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies

(2010) C. O'Keefe et al.   BLOOD

Pathophysiology of Waldenstrom's macroglobulinemia

(2010) M. J. Stone et al.   HAEMATOLOGICA

Oncogenically active MYD88 mutations in human lymphoma

(2010) Vu N. Ngo et al.   NATURE

Identification of Copy Number Abnormalities and Inactivating Mutations in Two Negative Regulators of Nuclear Factor- B Signaling Pathways in Waldenstrom's Macroglobulinemia

(2009) E. Braggio et al.   CANCER RESEARCH

Targeting NF- B in Waldenstrom macroglobulinemia

(2008) X. Leleu et al.   BLOOD

CD27-CD70 interactions in the pathogenesis of Waldenstrom macroglobulinemia

(2008) A. W. Ho et al.   BLOOD